BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND KMT2D, ENSG00000167548, 8085, MLL2 AND Treatment
6 results:

  • 1. Molecular and immunohistochemical comparison between primary gastrointestinal mucosal melanomas and atypical gastrointestinal stromal tumors.
    Song IH; Sung YE; Kang J; Lee A; Lee SH
    Pathol Res Pract; 2022 Dec; 240():154189. PubMed ID: 36327823
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies.
    Denisova E; Westphal D; Surowy HM; Meier F; Hutter B; Reifenberger J; Rütten A; Schulz A; Sergon M; Ziemer M; Brors B; Betz RC; Redler S
    Cancer Gene Ther; 2022 Jun; 29(6):697-708. PubMed ID: 34045664
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
    da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
    Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
    Alexandrescu DT
    Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Basal cell carcinoma: treatment with imiquimod.
    Bukhardt Pérez MP; Ruiz-Villaverde R; Naranjo Díaz MJ; Blasco Melguizo J; Naranjo Sintes R
    Int J Dermatol; 2007 May; 46(5):539-42. PubMed ID: 17472691
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Adjuvant therapy of malignant melanoma].
    Franke W; Neumann NJ; Ruzicka T; Schulte KW
    Praxis (Bern 1994); 2001 Feb; 90(8):301-6. PubMed ID: 11256332
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.